Fibromyalgia Review

REFERENCES

• Burckhardt C S, Clark S R, Bennett R M. Fibromyalgia and quality of life: A comparative analysis. J Rheumatol 1993; 20: 475–479
   PubMed Web of Science ®Google Scholar
• Martinez J E, Ferraz M B, Sato E I, Atra E. Fibromyalgia versus rheumatoid arthritis: A Longitudinal comparison of the quality of life. J Rheumatol 1995; 22: 270–274
   PubMed Web of Science ®Google Scholar
• Wolfe F, Hawley D J. Measurement of the quality of life in rheumatic disorders using the EuroQol. Br J Rheumatol 1997; 36(7)786–793
   PubMedGoogle Scholar
• Gladman D D, Urowitz M B, Gough J, MacKinnon A. Fibromyalgia is a major contributor to quality of life in lupus. J Rheumatol 1997; 24(11)2145–2148
   PubMed Web of Science ®Google Scholar
• Lindberg L, Iwarsson S. Subjective quality of life, health, I-ADL ability and adaptation strategies in fibromyalgia. Clin Rehabil 2002; 16(6)675–683
   PubMed Web of Science ®Google Scholar
• Perrot S, Dumont D, Guillemin F, Pouchot J, Coste J. Quality of Life in Women with Fibromyalgia Syndrome: Validation of the QIF, the French Version of the Fibromyalgia Impact Questionnaire. J Rheumatol 2003; 30(5)1054–1059
   PubMed Web of Science ®Google Scholar
• Mariette X, Zerbib M, Jaccard A, Schenmetzler C, Danon F, Clauvel J P. Hepatitis C virus and Sjogren's syndrome. Arth Rheum 1993; 36: 280–281
   PubMedGoogle Scholar
• Barkhuizen A, Schoeplin G S, Bennett R M. Fibromyalgia: A prominent feature in patients with musculoskeletal problems in chronic hepatitis C: A report of 12 patients. J Clinical Rheumatology 1996; 2: 180–184
   PubMedGoogle Scholar
• Rivera J, Diego A, TM Monforte GA. Fibro-myalgia-associated hepatitis C virus infection. British Journal of Rheumatology 1997; 36: 981–985
   PubMedGoogle Scholar
• Buskila D, Shnaider A, Neumann L, Lorber M, Zilberman D, Hilzenrat N, et al. Musculoskeletal manifestations and autoantibody profile in 90 hepatitis C virus infected Israeli patients [In Process Citation]. Semin Arthritis Rheum 1998; 28(2)107–113
   PubMed Web of Science ®Google Scholar
• Goulding C, O'Connell P, Murray F E. Prevalence of fibromyalgia, anxiety and depression in chronic hepatitis C virus infection: Relationship to RT-PCR status and mode of acquisition. Eur J Gastroenterol Hepatol 2001; 13(5)507–511
   PubMed Web of Science ®Google Scholar
• Vassilopoulos D, Calabrese L H. Rheumatic manifestations of hepatitis C infection. Curr Rheumatol Rep 2003; 5(3)200–204
   PubMedGoogle Scholar
• Thompson M E, Barkhuizen A. Fibromyalgia, hepatitis C infection, and the cytokine connection. Curr Pain Headache Rep 2003; 7(5)342–347
   PubMedGoogle Scholar
• Wallace D J, Linker-Israeli M, Hallegua D, Silverman S, Silver D, Weisman M H. Cytokines play an aetiopathogenetic role in fibromyalgia: A hypothesis and pilot study. Rheumatology (Oxford) 2001; 40(7)743–749
   PubMed Web of Science ®Google Scholar
• Yousef G E, Mann G F, Smith D G, Bell E J, Murugesan V, McCartney R A, et al. Chronic enterovirus infection in patients with postviral fatigue syndrome. Lancet 1988; 146–149
   PubMed Web of Science ®Google Scholar
• Dowsett E G, Ramsay A M, McCartney R A, Bell E J. Myalgic encephalomyelitis-A persistent enteroviral infection?. Postgrad Med J 1990; 66: 526–530
   PubMed Web of Science ®Google Scholar
• Gow J W, Behan W MH, Clements G B, Woodall C, Riding M, Behan P O. Enteroviral RNA sequences detected by polymerase chain reaction in muscle of patients with postviral fatigue syndrome. BMJ 1991; 302: 692–696
   PubMed Web of Science ®Google Scholar
• Rabeneck L, Genta R M. Entero virus in the chronic fatigue syndrome. Ann Intern Med 1994; 120(11)972–973
   PubMed Web of Science ®Google Scholar
• Glass J M, Park D C. Cognitive dysfunction in fibromyalgia. Curr Rheumatol Rep 2001; 3(2)123–127
   PubMedGoogle Scholar
• Maurset A, Skoglund L A, Hustveit O, Oye I. Comparison of ketamine and pethidine in experimental and postoperative pain. Pain 1989; 36: 37–41
   PubMed Web of Science ®Google Scholar
• Stannard C F, Porter G E. Ketamine hydrochloride in the treatment of phantom limb pain. Pain 1993; 54: 227–230
   PubMed Web of Science ®Google Scholar
• Edwards N D, Fletcher A, Cole J R, Peacock J E. Combined infusions of morphine and ketamine for postoperative pain in elderly patients. Anaesthesia 1993; 48: 124–127
   PubMed Web of Science ®Google Scholar
• Backonja M, Arndt G, Gombar K A, Check B, Zimmermann M. Response of chronic neuropathic pain syndromes to ketamine: A preliminary study. Pain 1994; 56(1)51–57
   PubMed Web of Science ®Google Scholar
• Eide P K, Jorum E, Stubhaug A, Bremnes J, Breivik H. Relief of post-herpetic neuralgia with the N-methyl-D-aspartic acid receptor antagonist ketamine: A double-blind, cross-over comparison with morphine and placebo. Pain 1994; 58: 347–354
   PubMed Web of Science ®Google Scholar
• Hoffmann V, Coppejans H, Vercauteren M, Adriaensen H. Successful treatment of postherpetic neuralgia with oral ketamine. Clin J Pain 1994; 10: 240–242
   PubMed Web of Science ®Google Scholar
• Sorensen J, Bengtsson A, Backman E, Henriksson K G, Bengtsson M. Pain analysis in patients with fibromyalgia: Effects of intravenous morphine, lidocaine and ketamine. Scand J Rheumatol 1995; 24: 360–365
   PubMed Web of Science ®Google Scholar
• Arendt-Nielsen L, Petersen-Felix S, Fischer M, Bak P, Bjerring P, Zbinden A M. The effect of N-methyl-D-aspartate antagonist (ketamine) on single and repeated nociceptive stimuli: A placebo-controlled experimental human study. Anesth Analg 1995; 81: 63–68
   PubMed Web of Science ®Google Scholar
• Cherry D A, Plummer J L, Gourlay G K, Coates K R, Odgers C L. Ketamine as an adjunct to morphine in the treatment of pain. Pain 1995; 62: 119–121
   PubMed Web of Science ®Google Scholar
• Persson J, Axelsson G, Hallin R G, Gustafsson L L. Beneficial effects of ketamine in a chronic pain state with allodynia, possibly due to central sensitization. Pain 1995; 60: 217–222
   PubMed Web of Science ®Google Scholar
• Sorensen J, Bengtsson A, Ahlner J, Henriksson K G, Ekselius L, Bengtsson M. Fibromyalgia-are there different mechanisms in the processing of pain? A double blind crossover comparison of analgesic drugs. J Rheumatol 1997; 24(8)1615–1621
   PubMed Web of Science ®Google Scholar
• Graven-Nielsen T, Aspegren K S, Henriksson K G, Bengtsson M, Sorensen J, Johnson A, et al. Ketamine reduces muscle pain, temporal summation, and referred pain in fibromyalgia patients. Pain 2000; 85(3)483–491
   PubMed Web of Science ®Google Scholar